119 related articles for article (PubMed ID: 38527287)
1. Deep Learning to Estimate Cardiovascular Risk From Chest Radiographs : A Risk Prediction Study.
Weiss J; Raghu VK; Paruchuri K; Zinzuwadia A; Natarajan P; Aerts HJWL; Lu MT
Ann Intern Med; 2024 Apr; 177(4):409-417. PubMed ID: 38527287
[TBL] [Abstract][Full Text] [Related]
2. Deep Learning Using Chest Radiographs to Identify High-Risk Smokers for Lung Cancer Screening Computed Tomography: Development and Validation of a Prediction Model.
Lu MT; Raghu VK; Mayrhofer T; Aerts HJWL; Hoffmann U
Ann Intern Med; 2020 Nov; 173(9):704-713. PubMed ID: 32866413
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular risk assessment using ASCVD risk score in fibromyalgia: a single-centre, retrospective study using "traditional" case control methodology and "novel" machine learning.
Surendran S; Mithun CB; Moni M; Tiwari A; Pradeep M
Adv Rheumatol; 2021 Nov; 61(1):72. PubMed ID: 34838137
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for cardiovascular disease among individuals with hepatic steatosis.
Karády J; Ferencik M; Mayrhofer T; Meyersohn NM; Bittner DO; Staziaki PV; Szilveszter B; Hallett TR; Lu MT; Puchner SB; Simon TG; Foldyna B; Ginsburg GS; McGarrah RW; Voora D; Shah SH; Douglas PS; Hoffmann U; Corey KE
Hepatol Commun; 2022 Dec; 6(12):3406-3420. PubMed ID: 36281983
[TBL] [Abstract][Full Text] [Related]
5. Predicting cardiovascular disease risk across the atherosclerotic disease continuum.
Poppe KK; Wells S; Jackson R; Doughty RN; Kerr AJ
Eur J Prev Cardiol; 2022 Feb; 28(18):2010-2017. PubMed ID: 33624049
[TBL] [Abstract][Full Text] [Related]
6. Deep Learning to Assess Long-term Mortality From Chest Radiographs.
Lu MT; Ivanov A; Mayrhofer T; Hosny A; Aerts HJWL; Hoffmann U
JAMA Netw Open; 2019 Jul; 2(7):e197416. PubMed ID: 31322692
[TBL] [Abstract][Full Text] [Related]
7. Association between 5-year change in cardiovascular risk and the incidence of atherosclerotic cardiovascular diseases: a multi-cohort study.
Yi J; Wang L; Guo X; Ren X
J Transl Med; 2023 Sep; 21(1):589. PubMed ID: 37660053
[TBL] [Abstract][Full Text] [Related]
8. Validation of a Deep Learning-Based Model to Predict Lung Cancer Risk Using Chest Radiographs and Electronic Medical Record Data.
Raghu VK; Walia AS; Zinzuwadia AN; Goiffon RJ; Shepard JO; Aerts HJWL; Lennes IT; Lu MT
JAMA Netw Open; 2022 Dec; 5(12):e2248793. PubMed ID: 36576736
[TBL] [Abstract][Full Text] [Related]
9. Association between change in cardiovascular risk scores and future cardiovascular disease: analyses of data from the Whitehall II longitudinal, prospective cohort study.
Lindbohm JV; Sipilä PN; Mars N; Knüppel A; Pentti J; Nyberg ST; Frank P; Ahmadi-Abhari S; Brunner EJ; Shipley MJ; Singh-Manoux A; Tabak AG; Batty GD; Kivimäki M
Lancet Digit Health; 2021 Jul; 3(7):e434-e444. PubMed ID: 34167764
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular risk prediction in HIV-infected patients: comparing the Framingham, atherosclerotic cardiovascular disease risk score (ASCVD), Systematic Coronary Risk Evaluation for the Netherlands (SCORE-NL) and Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) risk prediction models.
Krikke M; Hoogeveen RC; Hoepelman AI; Visseren FL; Arends JE
HIV Med; 2016 Apr; 17(4):289-97. PubMed ID: 26268806
[TBL] [Abstract][Full Text] [Related]
11. Prediction of future cardiovascular events by Framingham, SCORE and asCVD risk scores is less accurate in HIV-positive individuals from the HIV-HEART Study compared with the general population.
Schulz CA; Mavarani L; Reinsch N; Albayrak-Rena S; Potthoff A; Brockmeyer N; Hower M; Erbel R; Jöckel KH; Schmidt B; Esser S;
HIV Med; 2021 Sep; 22(8):732-741. PubMed ID: 34028959
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of Large-Scale Proteomics for Prediction of Cardiovascular Events.
Helgason H; Eiriksdottir T; Ulfarsson MO; Choudhary A; Lund SH; Ivarsdottir EV; Hjorleifsson Eldjarn G; Einarsson G; Ferkingstad E; Moore KHS; Honarpour N; Liu T; Wang H; Hucko T; Sabatine MS; Morrow DA; Giugliano RP; Ostrowski SR; Pedersen OB; Bundgaard H; Erikstrup C; Arnar DO; Thorgeirsson G; Masson G; Magnusson OT; Saemundsdottir J; Gretarsdottir S; Steinthorsdottir V; Thorleifsson G; Helgadottir A; Sulem P; Thorsteinsdottir U; Holm H; Gudbjartsson D; Stefansson K
JAMA; 2023 Aug; 330(8):725-735. PubMed ID: 37606673
[TBL] [Abstract][Full Text] [Related]
13. Breast Arterial Calcification: a Novel Cardiovascular Risk Enhancer Among Postmenopausal Women.
Iribarren C; Chandra M; Lee C; Sanchez G; Sam DL; Azamian FF; Cho HM; Ding H; Wong ND; Molloi S
Circ Cardiovasc Imaging; 2022 Mar; 15(3):e013526. PubMed ID: 35290077
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular disease risk prediction by the American College of Cardiology (ACC)/American Heart Association (AHA) Atherosclerotic Cardiovascular Disease (ASCVD) risk score among HIV-infected patients in sub-Saharan Africa.
Mosepele M; Hemphill LC; Palai T; Nkele I; Bennett K; Lockman S; Triant VA
PLoS One; 2017; 12(2):e0172897. PubMed ID: 28235058
[TBL] [Abstract][Full Text] [Related]
15. Heterogeneity in the Association Between the Presence of Coronary Artery Calcium and Cardiovascular Events: A Machine-Learning Approach in the MESA Study.
Inoue K; Seeman TE; Horwich T; Budoff MJ; Watson KE
Circulation; 2023 Jan; 147(2):132-141. PubMed ID: 36314118
[TBL] [Abstract][Full Text] [Related]
16. The effect of vitamin D supplementation on cardiovascular risk in patients with prediabetes: A secondary analysis of the D2d study.
Desouza C; Chatterjee R; Vickery EM; Nelson J; Johnson KC; Kashyap SR; Lewis MR; Margolis K; Pratley R; Rasouli N; Sheehan PR; Pittas AG;
J Diabetes Complications; 2022 Aug; 36(8):108230. PubMed ID: 35753926
[TBL] [Abstract][Full Text] [Related]
17. Development and validation of a novel 10-year cardiovascular risk prediction nomogram for the United Arab Emirates national population.
Al-Shamsi S
BMJ Open; 2022 Dec; 12(12):e064502. PubMed ID: 36581433
[TBL] [Abstract][Full Text] [Related]
18. Extreme Atherosclerotic Cardiovascular Disease (ASCVD) Risk Recognition.
Rosenblit PD
Curr Diab Rep; 2019 Jul; 19(8):61. PubMed ID: 31332544
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of atherosclerotic cardiovascular disease and subsequent major adverse cardiovascular events in Alberta, Canada: A real-world evidence study.
Chen G; Farris MS; Cowling T; Pinto L; Rogoza RM; MacKinnon E; Champsi S; Anderson TJ
Clin Cardiol; 2021 Nov; 44(11):1613-1620. PubMed ID: 34585767
[TBL] [Abstract][Full Text] [Related]
20. Utility of Nontraditional Risk Markers in Individuals Ineligible for Statin Therapy According to the 2013 American College of Cardiology/American Heart Association Cholesterol Guidelines.
Yeboah J; Polonsky TS; Young R; McClelland RL; Delaney JC; Dawood F; Blaha MJ; Miedema MD; Sibley CT; Carr JJ; Burke GL; Goff DC; Psaty BM; Greenland P; Herrington DM
Circulation; 2015 Sep; 132(10):916-22. PubMed ID: 26224808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
